Neurogene Inc. (NGNE) Form 10-Q Quarterly Reports
Neurogene Inc. (NGNE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NGNE
CIK: 1404644
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMark Hanulak
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-07 | — | SCHEDULE 13G Filing | 0001137774-26-000205 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-06 | — | SCHEDULE 13G Filing | 0000053417-26-000058 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-22 | FORM 4 | 0001606302-26-000007 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097193 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001493152-26-038383 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003430 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001404644-26-000059 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001404644-26-000056 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-06 | FORM 4 | 0001543663-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001543663-26-000015 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | 8-K | 0001404644-26-000050 | View SEC Doc Filr Page |
| 424B5 | 2026-07-02 | — | 424B5 | 0001628280-26-046666 | View SEC Doc Filr Page |
| 424B5 | 2026-06-30 | — | 424B5 | 0001628280-26-046237 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001404644-26-000046 | View SEC Doc Filr Page |
| 4/A | 2026-06-16 | 2024-01-16 | FORM 4/A | 0001996804-26-000011 | View SEC Doc Filr Page |
| 4/A | 2026-06-16 | 2024-06-14 | FORM 4/A | 0001996804-26-000010 | View SEC Doc Filr Page |
| 4/A | 2026-06-16 | 2025-06-12 | FORM 4/A | 0001996804-26-000009 | View SEC Doc Filr Page |
| 3/A | 2026-06-16 | 2023-12-18 | FORM 3/A | 0001996804-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | 8-K | 0001404644-26-000044 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001404644-26-000040 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001404644-26-000038 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001404644-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-05-08 | 2026-05-06 | FORM 4 | 0001543663-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-05-07 | 2026-05-05 | FORM 4 | 0001934412-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-05-06 | — | 144 Filing | 0001968582-26-000406 | View SEC Doc Filr Page |